Metabolic engineering faces a fundamental challenge: designing microbial strains capable of producing high-value compounds at commercial scales. Traditional computational methods relied on stoichiometric models that do not learn from experimental data, or on tabular machine learning techniques that ignore the relational structure of biological knowledge. To address this limitation, Canopy emerges as a foundational model based on heterogeneous graphs that integrates ten public and proprietary data sources into a unified knowledge graph with millions of nodes and diverse edge types. This model encodes multimodal features using specialized foundational models (ESM-2 for proteins, MoLFormer for chemical compounds, and PubMedBERT for biomedical texts) and employs a heterogeneous graph Transformer with advanced techniques such as SignNet positional embeddings, Jumping Knowledge aggregation, and virtual nodes, trained with four self-supervised objectives. In the fermentation titer prediction task, Canopy achieves an R² of 0.41, significantly outperforming tabular baselines. This type of innovation not only accelerates biotechnological research but also opens the door to more efficient industrial applications. In this context, companies like Q2BSTUDIO offer artificial intelligence for businesses that enables the integration of advanced models like Canopy into customized workflows. Additionally, they develop custom applications for sectors such as biotechnology, pharmaceuticals, and fine chemicals, relying on AWS and Azure cloud services for scalability and business intelligence services like Power BI to visualize results interactively. The incorporation of AI agents and cybersecurity solutions complements a robust technological ecosystem, where custom software becomes the bridge between cutting-edge research and real-world production. Canopy represents a qualitative leap in metabolic modeling, and its practical implementation requires technology partners with strategic vision and integration capabilities.

.jpg)



